Published in Mol Cell Biol on July 01, 1984
Effect of 5' splice site mutations on splicing of the preceding intron. Mol Cell Biol (1990) 2.75
Spontaneous splicing mutations at the dihydrofolate reductase locus in Chinese hamster ovary cells. Mol Cell Biol (1986) 2.19
Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene. Nucleic Acids Res (1992) 1.83
In vivo recognition of a vertebrate mini-exon as an exon-intron-exon unit. Mol Cell Biol (1993) 1.60
BiP and immunoglobulin light chain cooperate to control the folding of heavy chain and ensure the fidelity of immunoglobulin assembly. Mol Biol Cell (1999) 1.58
Cell-specific expression of secreted versus membrane forms of immunoglobulin gamma 2b mRNA involves selective use of alternate polyadenylation sites. Mol Cell Biol (1985) 1.34
Sequences near the 3' secretion-specific polyadenylation site influence levels of secretion-specific and membrane-specific IgG2b mRNA in myeloma cells. Mol Cell Biol (1986) 1.16
A DNA insertion/deletion necessitates an aberrant RNA splice accounting for a mu heavy chain disease protein. Proc Natl Acad Sci U S A (1986) 1.08
Comparison of in vitro and in vivo splice site selection in kappa-immunoglobulin precursor mRNA. Mol Cell Biol (1988) 0.94
Generation of heavy-chain-only antibodies in mice. Proc Natl Acad Sci U S A (2006) 0.86
Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection. Nucleic Acids Res (1991) 0.75
An aberrant splicing using a 3' cryptic splice site within the CH1 exon induces truncated mu-chain production. Immunology (1995) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids. Cell (1977) 61.24
A new pair of M13 vectors for selecting either DNA strand of double-digest restriction fragments. Gene (1982) 59.01
The structure and evolution of the human beta-globin gene family. Cell (1980) 21.24
Further procedures for sequence analysis by computer. Nucleic Acids Res (1978) 18.94
Are snRNPs involved in splicing? Nature (1980) 15.47
On the formation of spontaneous deletions: the importance of short sequence homologies in the generation of large deletions. Cell (1982) 9.72
Variety in the level of gene control in eukaryotic cells. Nature (1982) 9.61
Genetic studies of the lac repressor. VII. On the molecular nature of spontaneous hotspots in the lacI gene of Escherichia coli. J Mol Biol (1978) 8.13
A mechanism for RNA splicing. Proc Natl Acad Sci U S A (1980) 7.76
Inhibition of intractable nucleases with ribonucleoside--vanadyl complexes: isolation of messenger ribonucleic acid from resting lymphocytes. Biochemistry (1979) 6.00
The synthesis and processing of the messenger RNAs specifying heavy and light chain immunoglobulins in MPC-11 cells. Cell (1978) 4.92
Synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells. I. Adaptation of the Merwin plasma cell tumor-11 to culture, cloning, and characterization of gamma globulin subunits. J Exp Med (1970) 4.26
Rate of somatic mutation in immunoglobulin production by mouse myeloma cells. Proc Natl Acad Sci U S A (1971) 3.83
High capacity gel preparative electrophoresis for purification of fragments of genomic DNA. Anal Biochem (1978) 3.42
Sequence of the cloned gene for the constant region of murine gamma 2b immunoglobulin heavy chain. Science (1979) 3.21
The metabolism of a poly(A) minus mRNA fraction in HeLa cells. Cell (1974) 3.17
Complete nucleotide sequence of immunoglobulin gamma2b chain gene cloned from newborn nouse DNA. Nature (1980) 2.97
Cloning of mouse myeloma cells and detection of rare variants. J Cell Physiol (1972) 2.63
An immunoglobulin deletion mutant with implications for the heavy-chain switch and RNA splicing. Nature (1980) 2.41
On immunoglobulin heavy chain gene switching: two gamma 2b genes are rearranged via switch sequences in MPC-11 cells but only one is expressed. Nucleic Acids Res (1982) 2.29
A mutant immunoglobulin light chain is formed by aberrant DNA- and RNA-splicing events. Nature (1980) 2.25
Beta Thalassemia: mutations which affect processing of the beta-Globin mRNA precursor. Cell (1980) 1.98
Molecular analysis of spontaneous somatic mutants. Nature (1977) 1.90
Processing of human beta-globin mRNA precursor to mRNA is defective in three patients with beta+-thalassemia. Proc Natl Acad Sci U S A (1980) 1.72
Structure of the constant and 3' untranslated regions of the murine gamma 2b heavy chain messenger RNA. Science (1979) 1.68
Synthesis of a carboxyl-terminal (constant region) fragment of the immunoglobulin light chain by a mouse myeloma cell line. J Mol Biol (1974) 1.54
A seven-base-pair deletion in an intron of the albumin gene of analbuminemic rats. Proc Natl Acad Sci U S A (1983) 1.52
Murine heavy chain disease. Eur J Immunol (1978) 1.50
An unusual translocation of immunoglobulin gene segments in variants of the mouse myeloma MPC11. Nature (1980) 1.45
Mutation in an intervening sequence splice junction in man. Proc Natl Acad Sci U S A (1981) 1.34
An IgG2a-producing variant of an IgG2b-producing mouse myeloma cell line. Structural studies on the Fc region of parent and variant heavy chains. Biochemistry (1978) 1.33
Probable nuclear precursors of preprolactin mRNA in rat pituitary cells. J Biol Chem (1981) 1.24
Heavy chain diseases: clinical features and molecular significance of the disordered immunoglobulin structure. Semin Hematol (1973) 1.23
Presence of albumin mRNA precursors in nuclei of analbuminemic rat liver lacking cytoplasmic albumin mRNA. Proc Natl Acad Sci U S A (1982) 1.17
Genetic mechanism accounting for precise immunoglobulin domain deletion in a variant of MPC 11 myeloma cells. Science (1979) 1.17
Structural variants of human and murine immunoglobulins. Contemp Top Mol Immunol (1975) 1.14
Two alpha heavy chain disease proteins with different genomic deletions demonstrate that nonexpressed alpha heavy chain genes contain methylated bases. Proc Natl Acad Sci U S A (1981) 1.13
A mouse immunoglobulin heavy chain deletion mutant: isolation of a cDNA clone and sequence analysis of the mRNA. Nucleic Acids Res (1980) 0.99
A gamma 2b-gamma 2a hybrid immunoglobulin heavy chain produced by a variant of the MPC 11 mouse myeloma cell line. Biochemistry (1980) 0.97
Somatically generated mouse myeloma variants synthesizing IgA half-molecules. J Exp Med (1981) 0.97
Inactivation of an acceptor RNA splice site by a short deletion in beta-thalassemia. J Biol Chem (1983) 0.92
Heavy-chain mutants derived from gamma 2b mouse myeloma: characterization of heavy-chain messenger ribonucleic acid, proteins, and secretion in delection mutants and messenger ribonucleic acid in gamma2a mutant progeny. Biochemistry (1981) 0.85
Recent duplication and germ-line diversification of rat immunoglobulin kappa chain gene joining segments. Proc Natl Acad Sci U S A (1982) 0.85
Structure of heavy chain from strain 13 guinea pig immunoglobulin-G(2). I. Isolation of cyanogen bromide fragments. Biochemistry (1971) 0.84
Solar eclipses and ancient artistic motifs. Science (1977) 0.78
A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell (1983) 18.86
Detection of specific hybridoma clones by replica immunoadsorption of their secreted antibodies. Proc Natl Acad Sci U S A (1979) 13.60
Natural history of acute coronary heart attacks. A community study. Br Heart J (1972) 8.55
Alternative poly(A) site selection in complex transcription units: means to an end? Nucleic Acids Res (1997) 5.64
Immunoglobulin gene expression in transformed lymphoid cells. Proc Natl Acad Sci U S A (1983) 5.18
Mutants of Escherichia coli with altered deoxyribonucleases. I. Isolation and characterization of mutants for exonuclease 3. J Mol Biol (1972) 3.65
Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci U S A (1984) 3.32
The metabolism of a poly(A) minus mRNA fraction in HeLa cells. Cell (1974) 3.17
hnRNP F influences binding of a 64-kilodalton subunit of cleavage stimulation factor to mRNA precursors in mouse B cells. Mol Cell Biol (2001) 2.91
Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J Gen Virol (1994) 2.83
Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J Immunol (1989) 2.42
Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J (1988) 2.40
Mass screening for mutants with altered DNases by microassay techniques. Methods Enzymol (1974) 2.18
Design and production of novel tetravalent bispecific antibodies. Nat Biotechnol (1997) 2.13
Natural history of unstable angina. Lancet (1972) 2.03
Increase in the 64-kDa subunit of the polyadenylation/cleavage stimulatory factor during the G0 to S phase transition. Proc Natl Acad Sci U S A (1998) 2.01
Mutations in immunoglobulin-producing mouse myeloma cells. Science (1973) 1.94
A quantitative difference in the immune response between male and female mice. Proc Soc Exp Biol Med (1968) 1.90
The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region. J Exp Med (1991) 1.88
Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. Biochemistry (1995) 1.87
Variants of a mouse myeloma cell line that synthesize immunoglobulin heavy chains having an altered serotype. Proc Natl Acad Sci U S A (1975) 1.87
Polypeptide products of nonsense mutations. I. Termination fragments from nonsense mutations in the Z gene of the lac operon of Escherichia coli. J Mol Biol (1970) 1.84
Chi, a promoter of generalized recombination in lambda phage, is present in immunoglobulin genes. Nature (1981) 1.79
Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction. J Immunol Methods (1992) 1.74
Heavy chain-producing variants of a mouse myeloma cell line. J Immunol (1975) 1.73
Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation. J Exp Med (1993) 1.73
Membrane-bound polyribosomes in HeLa cells: association of polyadenylic acid with membranes. J Mol Biol (1974) 1.70
Regulation of poly(A) site use during mouse B-cell development involves a change in the binding of a general polyadenylation factor in a B-cell stage-specific manner. Mol Cell Biol (1995) 1.66
Variants of mouse myeloma cells that produce short immunoglobulin heavy chains. Proc Natl Acad Sci U S A (1974) 1.66
Prognosis of new and worsening angina pectoris. Br Med J (1976) 1.59
Expression of the thyroid hormone receptor gene, erbAalpha, in B lymphocytes: alternative mRNA processing is independent of differentiation but correlates with antisense RNA levels. Nucleic Acids Res (1997) 1.55
IFN-gamma-mediated antimicrobial response. Indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth. J Immunol (1993) 1.53
Independent immunoglobulin class-switch events occurring in a single myeloma cell line. Mol Cell Biol (1985) 1.51
Murine heavy chain disease. Eur J Immunol (1978) 1.50
Products of a reciprocal chromosome translocation involving the c-myc gene in a murine plasmacytoma. Proc Natl Acad Sci U S A (1984) 1.50
NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3' alpha enhancer at early stages of B-cell differentiation. Mol Cell Biol (1993) 1.43
HeLa cell poly(A)- mRNA codes for a subset of poly(A)+ mRNA-directed proteins with an actin as a major product. Proc Natl Acad Sci U S A (1977) 1.42
A comparison of apparent mRNA half-life using kinetic labeling techniques vs decay following administration of transcriptional inhibitors. Anal Biochem (1991) 1.40
Estimation of antibodies specific for dextran. J Immunol (1978) 1.38
An enhancer at the 3' end of the mouse immunoglobulin heavy chain locus. Nucleic Acids Res (1991) 1.38
Production and properties of chimeric antibody molecules. Methods Enzymol (1989) 1.35
Membrane IgM, IgD, and IgG act as signal transmission molecules in a series of B lymphomas. J Immunol (1986) 1.34
IgG2a-producing variants of an IgG2b-producing mouse myeloma cell line. J Exp Med (1978) 1.34
Cell-specific expression of secreted versus membrane forms of immunoglobulin gamma 2b mRNA involves selective use of alternate polyadenylation sites. Mol Cell Biol (1985) 1.34
An IgG2a-producing variant of an IgG2b-producing mouse myeloma cell line. Structural studies on the Fc region of parent and variant heavy chains. Biochemistry (1978) 1.33
Effect of glycosylation on antibody function: implications for genetic engineering. Trends Biotechnol (1997) 1.32
Characterization of the J chain from polymeric immunoglobulins (IgA-IgM-immunological specificity-primary structure). Proc Natl Acad Sci U S A (1972) 1.31
Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor. Pharm Res (2000) 1.31
Regulation of immunoglobulin expression in mouse myeloma cells. Cold Spring Harb Symp Quant Biol (1977) 1.28
Different VL and VH germ-line genes are used to produce similar combining sites with specificity for alpha(1----6)dextrans. J Immunol (1987) 1.27
Preliminary mapping of mutations affecting exonuclease 3 in Escherichia coli K-12. J Bacteriol (1973) 1.26
Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins. Proc Natl Acad Sci U S A (1990) 1.26
Identification of 3' alpha-hs4, a novel Ig heavy chain enhancer element regulated at multiple stages of B cell differentiation. Nucleic Acids Res (1995) 1.24
Evidence that a single replication fork proceeds from early to late replicating domains in the IgH locus in a non-B cell line. Mol Cell (1999) 1.24
The HSV-1 UL45 gene product is not required for growth in Vero cells. Virology (1991) 1.21
Myeloma mutant with a novel 3' flanking region: loss of normal sequence and insertion of repetitive elements leads to decreased transcription but normal processing of the alpha heavy-chain gene products. Mol Cell Biol (1986) 1.21
DNA rearrangements in MPC-11 immunoglobulin heavy chain class-switch variants. Proc Natl Acad Sci U S A (1982) 1.21
Transfectomas provide novel chimeric antibodies. Science (1985) 1.20
Policy for early discharge after acute myocardial infarction. Br Med J (1980) 1.19
Left-handed Z-DNA and intramolecular triplex formation at the site of an unequal sister chromatid exchange. J Biol Chem (1990) 1.19
Regulated expression of the mouse gamma 2b Ig H chain gene is influenced by polyA site order and strength. J Immunol (1992) 1.18
Unequal sister chromatid exchange. A mechanism affecting Ig gene arrangement and expression. J Exp Med (1985) 1.18
The synthesis of ninety proteins including actin throughout the HeLa cell cycle. J Cell Biol (1978) 1.17
Genetic mechanism accounting for precise immunoglobulin domain deletion in a variant of MPC 11 myeloma cells. Science (1979) 1.17
Bone-marrow suppression associated with cimetidine. Ann Intern Med (1979) 1.17
Sequentially derived mutants of the constant region of the heavy chain of murine immunoglobulins. J Immunol (1979) 1.16
Sequences near the 3' secretion-specific polyadenylation site influence levels of secretion-specific and membrane-specific IgG2b mRNA in myeloma cells. Mol Cell Biol (1986) 1.16
Herpes simplex virus stromal keratitis is not titer-dependent and does not correlate with neurovirulence. Invest Ophthalmol Vis Sci (1989) 1.16
Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1. J Exp Med (1994) 1.16
Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells. J Immunol (1998) 1.15
Primary and secondary variants in immunoglobulin heavy chain production. Nature (1976) 1.15
Regulation of 3' IgH enhancers by a common set of factors, including kappa B-binding proteins. J Immunol (1996) 1.15
Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A. Proc Natl Acad Sci U S A (1987) 1.15
Transfer and expression of immunoglobulin genes. Annu Rev Immunol (1984) 1.15
Characterization of the interaction between the herpes simplex virus type I Fc receptor and immunoglobulin G. J Biol Chem (1999) 1.14
Two alpha heavy chain disease proteins with different genomic deletions demonstrate that nonexpressed alpha heavy chain genes contain methylated bases. Proc Natl Acad Sci U S A (1981) 1.13
The HSV-1 UL45 18 kDa gene product is a true late protein and a component of the virion. Virus Res (1993) 1.13
Immunochemical characterization of binding sites of hybridoma antibodies specific for alpha (1 leads to 6) linked dextran. Mol Immunol (1982) 1.12
The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain. J Exp Med (1991) 1.12
Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure. EMBO J (1991) 1.09
Plasma cell-regulated polyadenylation at the Ig gamma 2b secretion-specific poly(A) site. J Immunol (1992) 1.09
A nuclear DNA-binding protein expressed during early stages of B cell differentiation interacts with diverse segments within and 3' of the Ig H chain gene cluster. J Immunol (1992) 1.09
Ultraviolet-Stimulated KHCO(3) Efflux from Rose Cells: Regulation of Cytoplasmic pH. Plant Physiol (1983) 1.09
Evidence for an interaction of herpes simplex virus with chondroitin sulfate proteoglycans during infection. Virology (1995) 1.08
Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1. J Virol (2001) 1.08
Regulation of human papillomavirus type 31 polyadenylation during the differentiation-dependent life cycle. J Virol (1999) 1.06
The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes. J Exp Med (2000) 1.06
Dyad symmetry within the mouse 3' IgH regulatory region includes two virtually identical enhancers (C alpha3'E and hs3). J Immunol (1997) 1.05
Association constants of hybridoma antibodies specific for alpha (1 leads to 6) linked dextran determined by affinity electrophoresis. Mol Immunol (1982) 1.05
Virtually identical enhancers containing a segment of homology to murine 3'IgH-E(hs1,2) lie downstream of human Ig C alpha 1 and C alpha 2 genes. J Immunol (1997) 1.05
Sites of switch recombination in IgG2b- and IgG2a-producing hybridomas. J Immunol (1988) 1.05
The use of severe combined immunodeficiency mice to study the metabolism of human immunoglobulin G. Cancer (1994) 1.05
DNA regions flanking the mouse Ig 3' alpha enhancer are differentially methylated and DNAase I hypersensitive during B cell differentiation. J Immunol (1993) 1.04
Glycosylation of a VH residue of a monoclonal antibody against alpha (1----6) dextran increases its affinity for antigen. J Exp Med (1988) 1.03
B-lineage regulated polyadenylation occurs on weak poly(A) sites regardless of sequence composition at the cleavage and downstream regions. Nucleic Acids Res (1996) 1.03
Site of binding of mouse IgG2b to the Fc receptor on mouse macrophages. J Exp Med (1979) 1.02
The identification of mouse myeloma cells which have undergone mutations in immunoglobulin production. Soc Gen Physiol Ser (1974) 1.01